These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 14724389

  • 21. Failure of remyelination in the nonhuman primate optic nerve.
    Lachapelle F, Bachelin C, Moissonnier P, Nait-Oumesmar B, Hidalgo A, Fontaine D, Baron-Van Evercooren A.
    Brain Pathol; 2005 Jul; 15(3):198-207. PubMed ID: 16196386
    [Abstract] [Full Text] [Related]

  • 22. Ross River virus--induced demyelination: II. Ultrastructural studies.
    Seay AR, Wolinsky JS.
    Ann Neurol; 1983 Nov; 14(5):559-68. PubMed ID: 6316834
    [Abstract] [Full Text] [Related]

  • 23. Adhesive/repulsive properties in the injured spinal cord: relation to myelin phagocytosis by invading macrophages.
    Frisén J, Haegerstrand A, Fried K, Piehl F, Cullheim S, Risling M.
    Exp Neurol; 1994 Oct; 129(2):183-93. PubMed ID: 7957733
    [Abstract] [Full Text] [Related]

  • 24. Paranodal structural abnormalities in rat CNS myelin developing in vivo in the presence of implanted O1 hybridoma cells.
    Rosenbluth J, Liang WL, Liu Z, Guo D, Schiff R.
    J Neurocytol; 1995 Nov; 24(11):818-24. PubMed ID: 8576711
    [Abstract] [Full Text] [Related]

  • 25. Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice.
    Bieber AJ, Warrington A, Asakura K, Ciric B, Kaveri SV, Pease LR, Rodriguez M.
    Glia; 2002 Mar 01; 37(3):241-9. PubMed ID: 11857682
    [Abstract] [Full Text] [Related]

  • 26. Method of identifying natural antibodies for remyelination.
    Warrington AE, Rodriguez M.
    J Clin Immunol; 2010 May 01; 30 Suppl 1(0 1):S50-5. PubMed ID: 20387101
    [Abstract] [Full Text] [Related]

  • 27. Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord.
    Keirstead HS, Blakemore WF.
    J Neuropathol Exp Neurol; 1997 Nov 01; 56(11):1191-201. PubMed ID: 9370229
    [Abstract] [Full Text] [Related]

  • 28. Targeting of IgMkappa antibodies to oligodendrocytes promotes CNS remyelination.
    Asakura K, Miller DJ, Pease LR, Rodriguez M.
    J Neurosci; 1998 Oct 01; 18(19):7700-8. PubMed ID: 9742140
    [Abstract] [Full Text] [Related]

  • 29. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
    Meeson AP, Piddlesden S, Morgan BP, Reynolds R.
    Exp Neurol; 1994 Oct 01; 129(2):299-310. PubMed ID: 7525334
    [Abstract] [Full Text] [Related]

  • 30. Glial cell transplants that are subsequently rejected can be used to influence regeneration of glial cell environments in the CNS.
    Blakemore WF, Crang AJ, Franklin RJ, Tang K, Ryder S.
    Glia; 1995 Feb 01; 13(2):79-91. PubMed ID: 7649617
    [Abstract] [Full Text] [Related]

  • 31. Boundary cap cells are highly competitive for CNS remyelination: fast migration and efficient differentiation in PNS and CNS myelin-forming cells.
    Zujovic V, Thibaud J, Bachelin C, Vidal M, Coulpier F, Charnay P, Topilko P, Baron-Van Evercooren A.
    Stem Cells; 2010 Mar 31; 28(3):470-9. PubMed ID: 20039366
    [Abstract] [Full Text] [Related]

  • 32. Induction of oligodendrocyte proliferation and remyelination after chronic demyelination. Relevance to multiple sclerosis.
    Raine CS, Moore GR, Hintzen R, Traugott U.
    Lab Invest; 1988 Oct 31; 59(4):467-76. PubMed ID: 2459499
    [Abstract] [Full Text] [Related]

  • 33. Demyelination in the central nervous system mediated by an anti-oligodendrocyte antibody.
    Zhou L, Trapp BD, Miller RH.
    J Neurosci Res; 1998 Oct 15; 54(2):158-68. PubMed ID: 9788275
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis.
    Kerstetter AE, Padovani-Claudio DA, Bai L, Miller RH.
    Exp Neurol; 2009 Nov 15; 220(1):44-56. PubMed ID: 19616545
    [Abstract] [Full Text] [Related]

  • 35. CD44 is required for the migration of transplanted oligodendrocyte progenitor cells to focal inflammatory demyelinating lesions in the spinal cord.
    Piao JH, Wang Y, Duncan ID.
    Glia; 2013 Mar 15; 61(3):361-7. PubMed ID: 23280959
    [Abstract] [Full Text] [Related]

  • 36. Adenosine A1 receptor agonist, N6-cyclohexyladenosine, protects myelin and induces remyelination in an experimental model of rat optic chiasm demyelination; electrophysiological and histopathological studies.
    Asghari AA, Azarnia M, Mirnajafi-Zadeh J, Javan M.
    J Neurol Sci; 2013 Feb 15; 325(1-2):22-8. PubMed ID: 23260322
    [Abstract] [Full Text] [Related]

  • 37. Model for focal demyelination of the spinal dorsal columns of transgenic MBP-LacZ mice by phototargeted ablation of oligodendrocytes.
    Vanderluit JL, Bourque JA, Peterson AC, Tetzlaff W.
    J Neurosci Res; 2000 Oct 01; 62(1):28-39. PubMed ID: 11002285
    [Abstract] [Full Text] [Related]

  • 38. Dorsally-derived oligodendrocytes in the spinal cord contribute to axonal myelination during development and remyelination following focal demyelination.
    Zhu Q, Whittemore SR, Devries WH, Zhao X, Kuypers NJ, Qiu M.
    Glia; 2011 Nov 01; 59(11):1612-21. PubMed ID: 21710609
    [Abstract] [Full Text] [Related]

  • 39. Live imaging of remyelination after antibody-mediated demyelination in an ex-vivo model for immune mediated CNS damage.
    Harrer MD, von Büdingen HC, Stoppini L, Alliod C, Pouly S, Fischer K, Goebels N.
    Exp Neurol; 2009 Apr 01; 216(2):431-8. PubMed ID: 19320002
    [Abstract] [Full Text] [Related]

  • 40. ES cell-derived glial precursors contribute to remyelination in acutely demyelinated spinal cord lesions.
    Perez-Bouza A, Glaser T, Brüstle O.
    Brain Pathol; 2005 Jul 01; 15(3):208-16. PubMed ID: 16196387
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.